Syntal Capital Partners’s ResMed RMD Stock Holding History

Syntal Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,287	Closed	-$2.22M	–	130
2018 Q3	$2.22M	Buy	+19,287	New	+$2.11M	0.78%	37

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Syntal Capital Partners's RMD Position: Q4 2018 in Review

Syntal Capital Partners sold out of ResMed (RMD) in Q4 2018, closing a stake of 19,287 shares — an estimated $2.22M sold.

Syntal Capital Partners first reported a position in RMD in Q3 2018 and held it in 1 quarter. The position peaked at $2.22M in Q3 2018. 501 funds tracked by Wall St. Rank hold RMD as of Q4 2018.

Syntal Capital Partners reported no remaining ResMed position as of Q4 2018 after selling out during the quarter.
Syntal Capital Partners sold 19,287 ResMed shares in Q4 2018, an estimated $2.22M.
Syntal Capital Partners first reported a position in ResMed in Q3 2018 and held it in 1 quarter.
Syntal Capital Partners's ResMed position peaked at $2.22M in Q3 2018.
501 funds tracked by Wall St. Rank held ResMed as of Q4 2018.

Based on Syntal Capital Partners's 13F filing for Q4 2018, filed 13 Feb 2019.